Boston Scientific (BSX)

EBITDA Margin

27.77%

Quarterly · Period ending:

BSX logo

BSX EBITDA Margin

Latest reported27.77%
BSX Quarterly EBITDA Margin (100.00% → 27.77%)
High-resolution chart · PNG

BSX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific EBITDA Margin — Quarterly
Period endingEBITDA Margin
27.7655%
30.8091%
24.9905%
27.0089%
27.0105%
26.0991%
23.4817%
25.1129%
19.7087%
25.5187%
23.7584%
27.6439%
22.0895%
23.4878%
23.3498%
18.7066%
21.3317%
23.959%
15.9258%
28.6835%
16.2496%
24.782%
23.3752%
5.4908%
9.5357%
15.4149%
16.3855%
16.7713%
18.13%
32.0899%
24.0141%
31.216%
25.1807%
24.9685%
21.0133%
25.9226%
15.7732%
26.2963%
16.4765%
24.6081%
-6.7733%
24.7454%
-3.4884%
-5.8263%
21.2154%
10.5204%
-16.3222%
12.7844%
6.7806%
21.0259%
16.2677%
15.562%
21.2272%
-9.3697%
16.4745%
-24.7262%
-189.0044%
15.4877%
14.4481%
14.4077%
16.557%
24.9351%
23.3766%
19.9896%
17.9461%
-69.0816%
-52.6696%
8.5432%
19.19%
6.6169%
-108.4915%
8.8473%
22.9249%
25.1711%
-3.1119%
4.0527%
20.7629%
20.9492%
22.276%
17.1767%
16.9194%
33.0247%
32.6623%
-19.1264%
34.9412%
38.2043%
33.4375%
26.4507%
36.8493%
26.4325%
24.1747%
23.0594%
24.1218%
23.2962%
26.5356%
36.7036%
20.339%
21.037%
61.5953%
19.7015%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.